Liver injury in remdesivir-treated COVID-19 patients

MeSH terms

• Adenosine Monophosphate / administration & dosage
• Adenosine Monophosphate / adverse effects
• Adenosine Monophosphate / analogs & derivatives*
• Administration, Intravenous / methods
• Adult
• Aged
• Alanine / administration & dosage
• Alanine / adverse effects
• Alanine / analogs & derivatives*
• Antiviral Agents / administration & dosage
• Antiviral Agents / adverse effects
• Betacoronavirus / drug effects
• Betacoronavirus / isolation & purification
• COVID-19
• Chemical and Drug Induced Liver Injury* / diagnosis
• Chemical and Drug Induced Liver Injury* / prevention & control
• Compassionate Use Trials
• Coronavirus Infections* / blood
• Coronavirus Infections* / diagnosis
• Coronavirus Infections* / drug therapy
• Coronavirus Infections* / epidemiology
• Critical Illness / therapy*
• Dose-Response Relationship, Drug
• Drug Monitoring / methods
• Humans
• Italy / epidemiology
• Liver Function Tests / methods*
• Male
• Middle Aged
• Pandemics*
• Pneumonia, Viral* / blood
• Pneumonia, Viral* / diagnosis
• Pneumonia, Viral* / drug therapy
• Pneumonia, Viral* / epidemiology
• SARS-CoV-2
• Treatment Outcome